Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients.
Asberg A, Humar A, Rollag H, Jardine AG, Mouas H, Pescovitz MD, Sgarabotto D, Tuncer M, Noronha IL, Hartmann A; VICTOR Study Group. Asberg A, et al. Among authors: sgarabotto d. Am J Transplant. 2007 Sep;7(9):2106-13. doi: 10.1111/j.1600-6143.2007.01910.x. Epub 2007 Jul 19. Am J Transplant. 2007. PMID: 17640310 Free article. Clinical Trial.
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial.
Winston DJ, Saliba F, Blumberg E, Abouljoud M, Garcia-Diaz JB, Goss JA, Clough L, Avery R, Limaye AP, Ericzon BG, Navasa M, Troisi RI, Chen H, Villano SA, Uknis ME; 1263-301 Clinical Study Group. Winston DJ, et al. Am J Transplant. 2012 Nov;12(11):3021-30. doi: 10.1111/j.1600-6143.2012.04231.x. Epub 2012 Sep 4. Am J Transplant. 2012. PMID: 22947426 Free article. Clinical Trial.
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.
Navarro D, San-Juan R, Manuel O, Giménez E, Fernández-Ruiz M, Hirsch HH, Grossi PA, Aguado JM; ESGICH CMV Survey Study Group, on behalf of the European Study Group of Infections in Compromised Hosts (ESGICH) from the Society of Clinical Microbiology and Infectious Diseases (ESCMID). Navarro D, et al. Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12773. Epub 2017 Oct 25. Transpl Infect Dis. 2017. PMID: 28859257
Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study.
Winkler M, Pratschke J, Schulz U, Zheng S, Zhang M, Li W, Lu M, Sgarabotto D, Sganga G, Kaskel P, Chandwani S, Ma L, Petrovic J, Shivaprakash M. Winkler M, et al. Among authors: sgarabotto d. Transpl Infect Dis. 2010 Jun;12(3):230-7. doi: 10.1111/j.1399-3062.2009.00490.x. Epub 2010 Jan 11. Transpl Infect Dis. 2010. PMID: 20070619 Free PMC article.
Cytomegalovirus in transplantation - challenging the status quo.
Fishman JA, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt HJ, Sgarabotto D, Torre-Cisneros J, Uknis ME. Fishman JA, et al. Among authors: sgarabotto d. Clin Transplant. 2007 Mar-Apr;21(2):149-58. doi: 10.1111/j.1399-0012.2006.00618.x. Clin Transplant. 2007. PMID: 17425738 Review.
Torque Teno Virus: any pathological role in liver transplanted patients?
Burra P, Masier A, Boldrin C, Calistri A, Andreoli E, Senzolo M, Zorzi M, Sgarabotto D, Guido M, Cillo U, Canova D, Bendinelli M, Pistello M, Maggi F, Palù G. Burra P, et al. Among authors: sgarabotto d. Transpl Int. 2008 Oct;21(10):972-9. doi: 10.1111/j.1432-2277.2008.00714.x. Epub 2008 Jun 28. Transpl Int. 2008. PMID: 18564988 Free article. Clinical Trial.
Cytomegalovirus infection in solid organ transplant recipients.
Lumbreras C, Manuel O, Len O, ten Berge IJ, Sgarabotto D, Hirsch HH. Lumbreras C, et al. Among authors: sgarabotto d. Clin Microbiol Infect. 2014 Sep;20 Suppl 7:19-26. doi: 10.1111/1469-0691.12594. Clin Microbiol Infect. 2014. PMID: 26451404 Free article. Review. No abstract available.
Cell Therapy for Parkinson's Disease: A Translational Approach to Assess the Role of Local and Systemic Immunosuppression.
Aron Badin R, Vadori M, Vanhove B, Nerriere-Daguin V, Naveilhan P, Neveu I, Jan C, Lévèque X, Venturi E, Mermillod P, Van Camp N, Dollé F, Guillermier M, Denaro L, Manara R, Citton V, Simioni P, Zampieri P, D'avella D, Rubello D, Fante F, Boldrin M, De Benedictis GM, Cavicchioli L, Sgarabotto D, Plebani M, Stefani AL, Brachet P, Blancho G, Soulillou JP, Hantraye P, Cozzi E. Aron Badin R, et al. Among authors: d avella d, sgarabotto d. Am J Transplant. 2016 Jul;16(7):2016-29. doi: 10.1111/ajt.13704. Epub 2016 Mar 3. Am J Transplant. 2016. PMID: 26749114 Free article.
Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.
Abate D, Saldan A, Fiscon M, Cofano S, Paciolla A, Furian L, Ekser B, Biasolo MA, Cusinato R, Mengoli C, Bonfante L, Rossi B, Rigotti P, Sgarabotto D, Barzon L, Palù G. Abate D, et al. Among authors: sgarabotto d. J Infect Dis. 2010 Aug 15;202(4):585-94. doi: 10.1086/654931. J Infect Dis. 2010. PMID: 20594105
Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection.
Abate D, Fiscon M, Saldan A, Cofano S, Mengoli C, Sgarabotto D, d'Agostino C, Barzon L, Cusinato R, Toscano G, Feltrin G, Gambino A, Gerosa G, Palù G. Abate D, et al. Among authors: sgarabotto d, d agostino c. J Clin Microbiol. 2012 Jun;50(6):1974-80. doi: 10.1128/JCM.06406-11. Epub 2012 Mar 29. J Clin Microbiol. 2012. PMID: 22461674 Free PMC article.
59 results